W2P, in the last paragraph, Prof.Lubbert states that BioFrontera is going for an IPO, correct? In this senerio, doesn't DnaPrint investors get to participate thru this potential increase? What I am trying to understand is how.
BTW, I just made a miniscule investment in Sun City yesterday, and am still sitting on some serious cash, and am waiting for DNAP's pps to exceed my average.
Question: When Duchess Ltd buys it's shares, these shares come from DnaPrint directly? My lack of understanding in these matters is apparent, yet it seems to me that the registered "float" not already accounted for will be sold in lots to this consortium, thus forcing the MM's who cover DNAP to purchase at a higher price. Am I nuts? Are there ficticous shares floating around who's sellers will have to cover? How do the MM's get their shares to sell? Will these be accounted for?
My gut feeling is there are "shorts" in this arena whom I would like to see "clubbed like a baby seal": gutted. I have the money to move on if I am wrong and would rather paper my bathroom with my shares than sell.
Ok, I'm done venting.
Peace/Boat Drinks
News 
Market Data 
Discover 
AI
